Authors: Martha Powell, Future Science Group
Reporting from the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, April 22–25, Vienna, Austria), in this podcast we speak to Mahmoud Ghannoum from Case Western Reserve University and University Hospitals Cleveland Medical Center (both OH, USA).
In this interview Ghannoum highlights the importance of fungal research, and of considering the interactions between fungi and bacteria. Ghannoum has pioneered the characterization of the human mycobiome, the fungal component of the human microbiota, in addition to directing the Center for Medical Mycology at Case Western Reserve University.
Here, he discusses some of his current research and the implications of the mycobiome in both health and disease. Find out more about this exciting area, and Ghannoum’s highlights of the ECCMID conference in our interview above.
00.32 – First, could you introduce yourself and tell us a bit about your career to date?
01.09 – Why do you think fungal infections present a research area of unmet need?
03.11 – Could you outline the projects you’re currently working on?
04.46 – The microbiome has had a lot of interest in the last few years, and you have pioneered research into the fungal component, the mycobiome – do you feel the mycobiome is likely to be relevant to oral and intestinal health?
06.30 – Research at the Center for Medical Mycology at Case Western Reserve University combines basic and translational projects. Do you think a “bench to bedside” approach is important in your field?
07.25 – What do you think are the most promising strategies for overcoming the growing threat of antifungal resistance?
08.36 – In your opinion, what are the key hurdles to be overcome in this field?
10.45 – Finally, what has been your highlight of ECCMID 2017?